\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationHybrid: live Stockholm (Sweden) and on-line
ProgrammesThe EIT Community is working more closely with Higher Education Institutions (HEIs), helping them boost their innovation capacities at their core, turning universities into regional engines of innovation.
Join this event to learn more about the existing projects in the EIT Higher Education Initiative and how they are creating institutional change. The third call of this HEI initiative will be launched at the occasion of this event.
This event is part of the INNOVEIT WEEKS event series organised by the European Institute of Innovation and Technology and all details about registration and programme can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
